CHICAGO — A simple and inexpensive test for elevated white blood cell counts could be used to predict heart disease, a study of more than 66,000 women suggests.
Don't miss these Health stories
More women opting for preventive mastectomy - but should they be?
Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.
- Larry Page's damaged vocal cords: Treatment comes with trade-offs
- Report questioning salt guidelines riles heart experts
- CDC: 2012 was deadliest year for West Nile in US
- What stresses moms most? Themselves, survey says
- More women opting for preventive mastectomy - but should they be?
The study adds to the growing body of evidence that inflammation plays a role in strokes and heart attacks, perhaps by weakening blood vessels and causing fatty buildups inside them to break loose and create a blockage.
Women with the highest levels of white blood cells were found to be twice as likely to die from heart disease as women with the lowest levels. High white blood cell counts also were associated with a 40 percent higher risk for nonfatal heart attack and a 46 percent higher risk for stroke.
White blood cells are the body’s germ fighters. Their levels rise when the body is fighting infection from viruses and bacteria, and doctors routinely take a white blood cell count to diagnose various illnesses.
Current guidelines for predicting heart disease already direct doctors to test for another marker of inflammation, C-reactive protein, in some patients. But the white blood cell test is cheaper and more widely available. And it is as strong a predictor as C-reactive protein, the researchers said.
The study was published Monday in the Archives of Internal Medicine and was led by Dr. Karen Margolis, associate medical director of the Berman Center for Clinical Research in Minneapolis.
Test costs about $25
A white blood cell test costs about $25, she said, while a test for C-reactive protein costs about $75.
“It’s really a wake-up call for the profession,” he said. “Heart disease was not created by cholesterol alone.”
Which comes first, inflammation or damaged blood vessels, still is unknown. It is also unclear whether lowering white blood cell counts can lower the risk of heart attacks and strokes, Margolis said.
In the study, a white blood cell count did not have to be off the charts to predict heart disease death. Levels at the upper end of normal, or above 6.7 billion white blood cells per liter of blood, doubled the risk.
The study measured white blood cell counts once, then tracked the women for an average of six years. Researchers took into account other risk factors such as diet, smoking, age and physical activity.
The study is part of the Women’s Health Initiative, a research project of the National Institutes of Health that involves thousands of postmenopausal women across the country. Other WHI studies have uncovered the risks of taking hormones.
In an accompanying editorial, Dr. Mary Cushman of the University of Vermont called for more research to perfect inflammation testing. But Cushman cautioned that widespread screening for white blood cell counts could increase health-care costs and needlessly worry some patients.
© 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.